T-reg-derived IL-10 alters the myeloid compartment in the TME, indirectly providing regulation of T-cell-mediated anti-tumor immune responses through upregulation of T-cell stimulatory molecules such as major histocompatibility complex class II and CD80 on intra-tumor DCs [159]. The gene discussed is IL10; the disease is neoplasm.